Search
for
Sort by
Research 511–540 of 1000+
- Registrars’ Symposium: Summaries of Papers
- Targets to treat androgen excess in polycystic ovary syndrome
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Metabolic risk in PCOS: phenotype and adiposity impact
- Dermatological adverse events with taxane chemotherapy
- Obesity and the skin
- Adult polycystic ovary syndrome begins in childhood
- Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research
- A Simple Screening Approach for Assessing Community Prevalence and Phenotype of Polycystic Ovary Syndrome in a Semiurban Population in Sri Lanka
- Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- Diagnosis of hyperandrogenism: clinical criteria
- Dermatology of androgen-related disorders
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- PHYSIOLOGIC SKIN CHANGES ASSOCIATED WITH PREGNANCY
- Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris
- Emerging treatments in alopecia
- Idiopathic Hirsutism*
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Androgenic Hormone Profile of Adult Women with Acne
- A Clinical Approach to Severe Insulin Resistance
- Acne in women